Detection of treatment-induced changes in signaling pathways in gastrointestinal stromal tumors using transcriptomic data.
about
New perspectives for in vitro risk assessment of multiwalled carbon nanotubes: application of coculture and bioinformaticsIdentification of aberrant pathways and network activities from high-throughput dataSystems Approach to Identifying Relevant Pathways from Phenotype Information in Dose-Dependent Time Series Microarray DataImplications of systemic dysfunction for the etiology of malignancyIdentifying context-specific transcription factor targets from prior knowledge and gene expression dataOutlier Analysis and Top Scoring Pair for Integrated Data Analysis and Biomarker Discovery.A Kinetic-Model-Based Approach to Identify Malfunctioning Components in Signal Transduction Pathways from Artificial Clinical DataPatternMarkers & GWCoGAPS for novel data-driven biomarkers via whole transcriptome NMF.CoGAPS: an R/C++ package to identify patterns and biological process activity in transcriptomic data.Correcting transcription factor gene sets for copy number and promoter methylation variations.Drug repurposing identifies a synergistic combination therapy with imatinib mesylate for gastrointestinal stromal tumor.Learning dysregulated pathways in cancers from differential variability analysis.The non-negative matrix factorization toolbox for biological data mining.Preferential activation of the hedgehog pathway by epigenetic modulations in HPV negative HNSCC identified with meta-pathway analysisBeyond standard therapy: drugs under investigation for the treatment of gastrointestinal stromal tumor.CoGAPS matrix factorization algorithm identifies transcriptional changes in AP-2alpha target genes in feedback from therapeutic inhibition of the EGFR network.An argument for mechanism-based statistical inference in cancer.Tumor-derived exosomes: A message delivery system for tumor progression.Prospects for molecular staging of non-small-cell lung cancer from genomic alterations.Chemotherapy and signaling: How can targeted therapies supercharge cytotoxic agents?Array-based pharmacogenomics of molecular-targeted therapies in oncology.Toward Signaling-Driven Biomarkers Immune to Normal Tissue ContaminationBench to bedside and back again: personalizing treatment for patients with GISTGene expression signatures modulated by epidermal growth factor receptor activation and their relationship to cetuximab resistance in head and neck squamous cell carcinoma.Capturing drug responses by quantitative promoter activity profiling.Influence of selected anti-cancer drugs on the induction of DNA double-strand breaks and changes in gene expression in human hepatoma HepG2 cells.Integrated time course omics analysis distinguishes immediate therapeutic response from acquired resistance.Matrix Factorization for Transcriptional Regulatory Network Inference
P2860
Q23910479-B486A5CB-A2A2-442C-B063-6D24CED0033AQ26829854-C38EF77E-F200-4C7E-952F-4C24441DC0DEQ28393899-471AAED8-F3DC-43E8-825D-68FCE57A4CCFQ28708952-752789FB-C86B-429D-A8E8-9E05938359ACQ30630225-D74C0589-EA26-4B4F-B2DF-878BE3031304Q30992589-3462DCC9-C925-4D0E-AC00-74C68824DD39Q31033599-0A694767-3382-4D3F-AF14-A4EDEC6D7FECQ31160335-078D308E-D59D-406E-863C-A17BFB95F3D8Q33681694-4A265D77-C831-4E1D-A1D0-A44B10BC7F69Q34162960-2C40948D-AA06-48EC-B1A6-6EAB4ACA0F8FQ34289180-DE26FA34-C90B-4AC8-A939-7E4370D3315FQ34445068-CC6F5C6B-3947-4A58-BB11-2147CB42E15BQ34670961-49B77B9B-AB51-4723-AF77-9E6F400BFBBCQ35040800-1F31E571-87EC-4F88-A715-DDC24E5F9CB6Q36125976-F60BF793-D728-43CE-B584-146D94DAC7CCQ36138884-48F63835-982A-470D-858E-2F22BC446E27Q36182146-D2DD1C93-2878-4EE8-8ED2-B2F479B57950Q37716749-55DB96ED-19F9-4AA3-AEBF-10A0D5FBAEB2Q37775627-EC8409AC-4EDE-4144-8739-5D0DAD376CBDQ37799220-85AEA744-3258-40D5-B6E7-5BFB028BFDBDQ37976288-96C6ABE2-B42F-4584-BBBC-54A095806383Q38369788-3F25C48C-C8B2-499E-9284-1EC579506009Q39148688-4DE79867-392C-40A7-BD47-9EF35EA1068EQ39355591-E90BDE01-B85A-4104-8E3A-C23AC49767BAQ39756394-1956CD43-2B5A-471C-B6AC-2157BC43DD27Q51332973-2750A887-6582-404D-83EB-D2D6D2E9D326Q54964630-6A612119-10AD-47D6-9412-9262C235DE81Q59088996-BA46092A-D9C7-4650-943E-71A82A7B964F
P2860
Detection of treatment-induced changes in signaling pathways in gastrointestinal stromal tumors using transcriptomic data.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Detection of treatment-induced ...... ors using transcriptomic data.
@ast
Detection of treatment-induced ...... ors using transcriptomic data.
@en
Detection of treatment-induced ...... ors using transcriptomic data.
@nl
type
label
Detection of treatment-induced ...... ors using transcriptomic data.
@ast
Detection of treatment-induced ...... ors using transcriptomic data.
@en
Detection of treatment-induced ...... ors using transcriptomic data.
@nl
prefLabel
Detection of treatment-induced ...... ors using transcriptomic data.
@ast
Detection of treatment-induced ...... ors using transcriptomic data.
@en
Detection of treatment-induced ...... ors using transcriptomic data.
@nl
P2093
P2860
P1433
P1476
Detection of treatment-induced ...... ors using transcriptomic data.
@en
P2093
Andrew K Godwin
Burton Eisenberg
Michael F Ochs
Sarah Mburu
Takahiro Taguchi
P2860
P304
P356
10.1158/0008-5472.CAN-09-1709
P407
P577
2009-11-10T00:00:00Z